Beneficial ownership — 13D / 13G
87,281 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | VKTX Viking Therapeutics, Inc. | 13G/A | 5.1% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | EPAC Enerpac Tool Group Corp | 13G/A | 6.2% | Dec 31, 2023 | 2y |
| FIR TREE CAPITAL MANAGEMENT LP | SHAP Spree Acquisition Corp. 1 Limited | 13G | 7.12% | Dec 31, 2023 | 2y |
| Walleye Capital LLC | QOMO Qomolangma Acquisition Corp. Common Stock | 13G | 8.39% | Dec 31, 2023 | 2y |
| Crestview Partners III GP, L.P. | PLGO Pelagos Insurance Capital Ltd | 13G | 14.4% | Dec 31, 2023 | 2y |
| Advent International, L.P. | DH Definitive Healthcare Corp. | 13G/A | 53.7% | Dec 31, 2023 | 2y |
| JANUS HENDERSON GROUP PLC | LXEO Lexeo Therapeutics, Inc. | 13G | 8.7% | Dec 31, 2023 | 2y |
| Deep Track Capital, LP | GERN Geron Corp | 13G/A | 5.45% | Dec 31, 2023 | 2y |
| HGC Investment Management Inc. | KVACF Keen Vision Acquisition Corp. | 13G | 6.2% | Dec 31, 2023 | 2y |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | PRTS CarParts.com, Inc. | 13G/A | 6.48% | Dec 31, 2023 | 2y |
| WCAS XIII Carbon Analytics Acquisition, L.P. | CWAN Clearwater Analytics Holdings, Inc. | 13G/A | 26.9% | Dec 31, 2023 | 2y |
| J. Kyle Derham | NPWR Net Power Inc. | 13G/A | 6.1% | Dec 31, 2023 | 2y |
| Nokomis Capital, L.L.C. | CNTY Century Casinos Inc | 13G | 5.9% | Dec 31, 2023 | 2y |
| Divesh Makan | GTLB Gitlab Inc. | 13G/A | 9.5% | Dec 31, 2023 | 2y |
| COHEN & STEERS, INC. | WPC W. P. Carey Inc. | 13G | 5.21% | Dec 31, 2023 | 2y |
| 3G Global Food Holdings LP | KHC Kraft Heinz Co | 13G/A | 0% | Dec 31, 2023 | 2y |
| BAKER BROS. ADVISORS LP | SGMT Sagimet Biosciences Inc. | 13G | 6.8% | Dec 31, 2023 | 2y |
| Fourthstone LLC | AVBH Avidbank Holdings, Inc. | 13G/A | 9.89% | Dec 31, 2023 | 2y |
| First Trust Capital Management L.P. | PGSS Pegasus Digital Mobility Acquisition Corp. | 13G | 8.78% | Dec 31, 2023 | 2y |
| Palo Alto Investors LP | KPTI Karyopharm Therapeutics Inc. | 13G/A | 4.45% | Dec 31, 2023 | 2y |
| Alpha Wave Global, LP | MVLA Movella Holdings Inc. Common Stock | 13G | 0% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | ARVN Arvinas, Inc. | 13G | 5.6% | Dec 31, 2023 | 2y |
| VIKING GLOBAL INVESTORS LP | DNA Ginkgo Bioworks Holdings, Inc. | 13G/A | 8.8% | Dec 31, 2023 | 2y |
| PERCEPTIVE ADVISORS LLC | MGTX MeiraGTx Holdings plc | 13D/A | 18% | Dec 31, 2023 | 2y |
| Calvin Choi | HKD AMTD Digital Inc. | 13G/A | 14.2% | Dec 31, 2023 | 2y |
| Amundi | PLNT Planet Fitness, Inc. | 13G | 5.5% | Dec 31, 2023 | 2y |
| Alger Associates, Inc. 13-3017981 | CYRX Cryoport, Inc. | 13G/A | 4.1% | Dec 31, 2023 | 2y |
| PERCEPTIVE ADVISORS LLC | VERU Veru Inc. | 13G/A | 3.8% | Dec 31, 2023 | 2y |
| Westchester Capital Management, LLC | TLGYF Tlgy Acquisition Corp | 13G | 7.09% | Dec 31, 2023 | 2y |
| G. Leonard Baker, Jr. | CORT Corcept Therapeutics Inc | 13G/A | 5.3% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | VRTS Virtus Investment Partners, Inc. | 13G | 5.6% | Dec 31, 2023 | 2y |
| John P. Szabo, Jr. | INVE INVE Technologies, Inc. | 13G/A | 8.6% | Dec 31, 2023 | 2y |
| CITADEL ADVISORS LLC | KVSA Khosla Ventures Acquisition Co. Class A Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| Nut Tree Capital Management, LP | AVAH Aveanna Healthcare Holdings, Inc. | 13G | 6.5% | Dec 31, 2023 | 2y |
| Leonardo dos Santos Poça D’Água | STIX Semantix, Inc. Class A Ordinary Shares | 13G/A | 33.1% | Dec 31, 2023 | 2y |
| P SCHOENFELD ASSET MANAGEMENT LP | XAGE Longevity Health Holdings, Inc. | 13G/A | 0.5% | Dec 31, 2023 | 2y |
| CANADA PENSION PLAN INVESTMENT BOARD | WOOF Petco Health & Wellness Company, Inc. | 13G/A | 30.6% | Dec 31, 2023 | 2y |
| Theodore J. Leonsis | SG Sweetgreen, Inc. | 13G/A | 0.2% | Dec 31, 2023 | 2y |
| 8 KNOTS MANAGEMENT, LLC | EHTH eHealth, Inc. | 13G/A | 8.45% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | TW Tradeweb Markets Inc. | 13G | 7% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | FREE Whole Earth Brands, Inc. Class A Common Stock | 13G/A | 5.02% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | KVUE Kenvue Inc. | 13G | 5.7% | Dec 31, 2023 | 2y |
| GLAZER CAPITAL, LLC | ASCBF ASPAC II Acquisition Corp. | 13G/A | 2.18% | Dec 31, 2023 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | FDMT 4D Molecular Therapeutics, Inc. | 13G/A | 9.4% | Dec 31, 2023 | 2y |
| Deep Track Capital, LP | NRIX Nurix Therapeutics, Inc. | 13G/A | 6.18% | Dec 31, 2023 | 2y |
| D. E. Shaw & Co., L.P. | IRRX Integrated Rail and Resources Acquisition Corp. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Antara Capital LP | RVNC Revance Therapeutics, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Clal Insurance Enterprises Holdings Ltd | ELLO Ellomay Capital Ltd. | 13G/A | 12.2% | Dec 31, 2023 | 2y |
| COHEN & STEERS, INC. | IRM Iron Mountain Inc | 13G | 7.85% | Dec 31, 2023 | 2y |
| Anson Funds Management LP | SPRO Spero Therapeutics, Inc. | 13G | 8.1% | Dec 31, 2023 | 2y |